Carbogenics Ltd 31/05/2026 iXBRL

Company registration number: SC532460

Carbogenics Ltd

Unaudited filleted financial statements

31 May 2026

Carbogenics Ltd

Contents

Directors and other information

Statement of financial position

Statement of changes in equity

Notes to the financial statements

Carbogenics Ltd

Directors and other information


	Directors	L Krzynowek
		R Kennedy
		E Craig
		C Preston
		A Schofield


	Company number	SC532460


	Registered office	125 Princes Street
		Edinburgh
		EH2 4AD


	Business address	Suite 2, Ground Floor
		Orchard Brae House
		30 Queensferry Road
		Edinburgh
		EH4 2HS

Carbogenics Ltd

Statement of financial position

31 May 2026

		2026		2025
	Note	£	£	£	£

Fixed assets
Intangible assets	5	31,220		46,832
Tangible assets	6	32,763		41,764
		_______		_______
			63,983		88,596

Current assets
Stocks		24,767		27,222
Debtors	7	71,632		39,461
Cash at bank and in hand		385,768		99,664
		_______		_______
		482,167		166,347
Creditors: amounts falling due
within one year	8	32,630		59,002
		_______		_______
Net current assets			514,797		225,349
			_______		_______
Total assets less current liabilities			578,780		313,945

Creditors: amounts falling due
after more than one year	9		-		( 1,780)
			_______		_______
Net assets			578,780		312,165
			_______		_______

Capital and reserves
Called up share capital			190		161
Share premium account			3,194,400		2,250,695
Profit and loss account			( 2,615,810)		( 1,938,691)
			_______		_______
Shareholders funds			578,780		312,165
			_______		_______

For the year ending 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 09 July 2026 , and are signed on behalf of the board by:

L Krzynowek

Director

Company registration number: SC532460

Carbogenics Ltd

Statement of changes in equity

Year ended 31 May 2026

	Called up share capital	Share premium account	Profit and loss account	Total
	£	£	£	£


At 1 May 2022	141	1,851,867	( 1,588,119)	263,889

Loss for the year			( 350,572)	( 350,572)
	_______	_______	_______	_______
Total comprehensive income for the year	-	-	( 350,572)	( 350,572)

Issue of shares	20	398,828		398,848
	_______	_______	_______	_______
Total investments by and distributions to owners	20	398,828	-	398,848

	_______	_______	_______	_______
At 31 May 2025 and 1 June 2025	161	2,250,695	( 1,938,691)	312,165

Loss for the year			( 677,119)	( 677,119)
	_______	_______	_______	_______
Total comprehensive income for the year	-	-	( 677,119)	( 677,119)

Issue of shares	29	943,705		943,734
	_______	_______	_______	_______
Total investments by and distributions to owners	29	943,705	-	943,734

	_______	_______	_______	_______
At 31 May 2026	190	3,194,400	( 2,615,810)	578,780
	_______	_______	_______	_______

Carbogenics Ltd

Notes to the financial statements

Year ended 31 May 2026

1. General information

The company is a private company limited by shares, registered in Scotland. The address of the registered office is 5th Floor, 125 Princes Street, Edinburgh, EH2 4AD.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Intangible assets

Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at a revalued amount, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Research and development

Research expenditure is written off in the year in which it is incurred. Development expenditure incurred is capitalised as an intangible asset only when all of the following criteria are met: - It is technically feasible to complete the intangible asset so that it will be available for use or sale; - There is the intention to complete the intangible asset and use or sell it; - There is the ability to use or sell the intangible asset; - The use or sale of the intangible asset will generate probable future economic benefits; - There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and - The expenditure attributable to the intangible asset during its development can be measured reliably. Expenditure that does not meet the above criteria is expensed as incurred.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

Government grants

Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model and the performance model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset. Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 11 (2025: 10 ).

5. Intangible assets

	Other intangible assets	Total
	£	£
Cost
At 1 June 2025 and 31 May 2026	156,116	156,116
	_______	_______
Amortisation
At 1 June 2025	109,284	109,284
Charge for the year	15,612	15,612
	_______	_______
At 31 May 2026	124,896	124,896
	_______	_______
Carrying amount
At 31 May 2026	31,220	31,220
	_______	_______
At 31 May 2025	46,832	46,832
	_______	_______

6. Tangible assets

	Fixtures, fittings and equipment	Total
	£	£
Cost
At 1 June 2025	90,813	90,813
Additions	11,452	11,452
	_______	_______
At 31 May 2026	102,265	102,265
	_______	_______
Depreciation
At 1 June 2025	49,049	49,049
Charge for the year	20,453	20,453
	_______	_______
At 31 May 2026	69,502	69,502
	_______	_______
Carrying amount
At 31 May 2026	32,763	32,763
	_______	_______
At 31 May 2025	41,764	41,764
	_______	_______

7. Debtors

	2026	2025
	£	£
Trade debtors	60,408	38,176
Other debtors	11,224	1,285
	_______	_______
	71,632	39,461
	_______	_______

8. Creditors: amounts falling due within one year

	2026	2025
	£	£
Bank loans and overdrafts	2,497	14,687
Trade creditors	51,369	15,317
Corporation tax	( 106,284)	( 93,893)
Social security and other taxes	12,165	-
Other creditors	7,623	4,887
	_______	_______
	( 32,630)	( 59,002)
	_______	_______

9. Creditors: amounts falling due after more than one year

	2026	2025
	£	£
Other creditors	-	1,780
	_______	_______